Celltrion, Inc. et al v. Genentech, Inc. et al
| Celltrion, Inc., Celltrion Healthcare Co., Ltd.,, Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals International GmbH |
| Genentech, Inc., Biogen Inc., Hoffmann-La Roche Inc. and City of Hope |
| 3:2018cv00276 |
| January 11, 2018 |
| US District Court for the Northern District of California |
| San Francisco Office |
| San Mateo |
| William H. Orrick |
| Patent |
| 28 U.S.C. ยง 2201 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
53
ORDER RE: REVISED DATES FOR BRIEFING AND HEARING ON DEFENDANTS' 47 MOTION TO DISMISS PURSUANT TO L.R. 6-2 AND 7-12. Motion Hearing reset for 4/18/2018 02:00 PM in San Francisco, Courtroom 02, 17th Floor before Judge William H. Orrick. Signed by Judge William H. Orrick on 03/13/2018. (jmdS, COURT STAFF) (Filed on 3/13/2018)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the California Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
